Smith & Nephew (SNN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Smith & Nephew Revenue Highlights

Latest Revenue (Y)

$5.55B

Latest Revenue (Q)

$2.79B

Main Segment (Y)

Orthopaedics, Sports Medicine and ENT and Advanced Wound Management

Main Geography (Y)

United States of America

Smith & Nephew Revenue by Period

Smith & Nephew Revenue by Year

Date	Revenue	Change
2023-12-31	$5.55B	6.40%
2022-12-31	$5.21B	0.06%
2021-12-31	$5.21B	14.30%
2020-12-31	$4.56B	-11.25%
2019-12-31	$5.14B	4.77%
2018-12-31	$4.90B	2.92%
2017-12-31	$4.76B	2.06%
2016-12-31	$4.67B	0.76%
2015-12-31	$4.63B	0.37%
2014-12-31	$4.62B	6.11%
2013-12-31	$4.35B	5.17%
2012-12-31	$4.14B	-3.11%
2011-12-31	$4.27B	7.77%
2010-12-31	$3.96B	5.04%
2009-12-31	$3.77B	-0.76%
2008-12-31	$3.80B	12.82%
2007-12-31	$3.37B	21.23%
2006-12-31	$2.78B	8.89%
2005-12-31	$2.55B	6.57%
2004-12-31	$2.39B	13.75%
2003-12-31	$2.11B	17.76%
2002-12-31	$1.79B	13.49%
2001-12-31	$1.58B	-7.06%
2000-12-31	$1.69B	-6.45%
1999-12-31	$1.81B	3.61%
1998-12-31	$1.75B	0.92%
1997-12-31	$1.73B	-5.37%
1996-12-31	$1.83B	15.46%
1995-12-31	$1.59B	5.16%
1994-12-31	$1.51B	7.46%
1993-12-31	$1.40B	-

Smith & Nephew generated $5.55B in revenue during NA 2023, up 6.40% compared to the previous quarter, and up 113.15% compared to the same period a year ago.

Smith & Nephew Revenue by Quarter

Date	Revenue	Change
2023-12-31	$2.79B	2.14%
2023-07-01	$2.73B	100.00%
2023-04-01	$1.37B	-50.16%
2022-12-31	$2.74B	109.79%
2022-09-30	$1.31B	-49.71%
2022-07-02	$2.60B	100.00%
2022-04-02	$1.30B	-50.71%
2021-12-31	$2.64B	101.86%
2021-09-30	$1.31B	-49.73%
2021-07-03	$2.60B	100.00%
2021-04-03	$1.30B	-47.60%
2020-12-31	$2.48B	96.42%
2020-09-30	$1.26B	-37.96%
2020-06-27	$2.04B	100.00%
2020-03-27	$1.02B	-62.16%
2019-12-31	$2.69B	102.69%
2019-09-30	$1.33B	-46.62%
2019-06-29	$2.48B	100.00%
2019-03-29	$1.24B	-49.57%
2018-12-31	$2.46B	100.00%
2018-09-30	$1.23B	-49.51%
2018-06-30	$2.44B	100.00%
2018-03-31	$1.22B	-49.77%
2017-12-31	$2.43B	100.00%
2017-09-30	$1.21B	-48.01%
2017-07-01	$2.34B	100.00%
2017-04-01	$1.17B	-50.11%
2016-12-31	$2.34B	100.00%
2016-09-30	$1.17B	-49.72%
2016-07-02	$2.33B	100.00%
2016-04-02	$1.16B	-50.72%
2015-12-31	$2.36B	3.96%
2015-06-27	$2.27B	-5.21%
2014-12-31	$2.40B	108.80%
2014-09-30	$1.15B	-48.29%
2014-06-28	$2.22B	106.90%
2014-03-31	$1.07B	-51.27%
2013-12-31	$2.20B	114.41%
2013-09-30	$1.03B	-52.21%
2013-06-29	$2.15B	99.91%
2013-03-31	$1.07B	-0.19%
2012-12-31	$1.08B	13.13%
2012-09-30	$952.00M	-7.48%
2012-06-30	$1.03B	-4.63%
2012-03-31	$1.08B	-2.44%
2011-12-31	$1.11B	7.17%
2011-09-30	$1.03B	-4.18%
2011-06-30	$1.08B	2.09%
2011-03-31	$1.05B	-1.12%
2010-12-31	$1.07B	13.39%
2010-09-30	$941.00M	-1.88%
2010-06-30	$959.00M	-3.62%
2010-03-31	$995.00M	-6.66%
2009-12-31	$1.07B	16.50%
2009-09-30	$915.00M	-1.19%
2009-06-30	$926.00M	7.05%
2009-03-31	$865.00M	-9.90%
2008-12-31	$960.00M	3.23%
2008-09-30	$930.00M	-7.00%
2008-06-30	$1.00B	9.77%
2008-03-31	$911.00M	-5.79%
2007-12-31	$967.00M	14.44%
2007-09-30	$845.00M	3.94%
2007-06-30	$813.00M	9.27%
2007-03-31	$744.00M	-3.50%
2006-12-31	$771.00M	13.55%
2006-09-30	$679.00M	-1.02%
2006-06-30	$686.00M	6.69%
2006-03-31	$643.00M	-262.53%
2005-12-31	$-395.62M	-165.76%
2005-09-30	$601.64M	-4.15%
2005-06-30	$627.65M	-0.05%
2005-03-31	$628.00M	-11.08%
2004-12-31	$706.27M	26.90%
2004-09-30	$556.56M	-0.33%
2004-06-30	$558.40M	0.33%
2004-03-31	$556.59M	-12.49%
2003-12-31	$636.03M	23.76%
2003-09-30	$513.90M	-0.51%
2003-06-30	$516.54M	17.69%
2003-03-31	$438.89M	41.94%
2002-12-31	$309.21M	-38.57%
2002-09-30	$503.34M	25.42%
2002-06-30	$401.32M	-11.65%
2002-03-31	$454.24M	36.02%
2001-12-31	$333.94M	-10.42%
2001-09-30	$372.78M	-3.90%
2001-06-30	$387.89M	-0.09%
2001-03-31	$388.23M	-40.19%
2000-12-31	$649.08M	113.10%
2000-09-30	$304.59M	-

Smith & Nephew generated $2.79B in revenue during Q4 2023, up 2.14% compared to the previous quarter, and up 107.41% compared to the same period a year ago.

Smith & Nephew Revenue Breakdown

Smith & Nephew Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Advanced Wound Management	$1.61B	$1.51B	$1.50B	$1.31B	$1.38B
Orthopaedics, Sports Medicine and Ear Nose and Throat	$3.94B	$3.70B	$3.72B	-	-
Orthopaedics, Sports Medicine and ENT and Advanced Wound Management	$5.55B	$5.21B	$5.21B	-	-
Orthopaedics Sports Medicine And Ent And Advanced Wound Management	-	-	-	$4.56B	$5.14B
Orthopaedics Sports Medicine And Ear Nose And Throat	-	-	-	$3.25B	$3.76B

Smith & Nephew's latest annual revenue breakdown by segment (product or service), as of Dec 23: Orthopaedics, Sports Medicine and ENT and Advanced Wound Management (50.00%), Orthopaedics, Sports Medicine and Ear Nose and Throat (35.53%), and Advanced Wound Management (14.47%).

Smith & Nephew Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
United States of America	$2.76B	$2.66B	-	-	-
China	$319.00M	$352.00M	-	-	-
C	-	-	$318.00M	$336.00M	-
U	-	-	$2.34B	$2.55B	$2.35B
G	-	-	$166.00M	$211.00M	$211.00M

Smith & Nephew's latest annual revenue breakdown by geography, as of Dec 22: United States of America (89.65%), and China (10.35%).

Smith & Nephew Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SNN	Smith & Nephew	$5.55B	$2.79B
BRKR	Bruker	$2.96B	$800.70M
ITGR	Integer	$1.60B	$746.27M
GMED	Globus Medical	$1.57B	$625.71M
CNMD	CONMED	$1.24B	$316.70M
LIVN	LivaNova	$1.15B	$318.11M
IRTC	iRhythm	$492.68M	$147.54M
ATEC	Alphatec	$482.26M	$47.99M
GKOS	Glaukos	$314.71M	$96.67M
FNA	Paragon 28	$216.39M	$61.02M
KIDS	OrthoPediatrics	$148.73M	$52.80M
CFMS	Conformis	$62.05M	$13.02M
MOTS	Motus GI	$319.00K	$64.00K
OFIX	Orthofix Medical	$100.00K	$198.62M

SNN Revenue FAQ

What is Smith & Nephew’s yearly revenue?

Smith & Nephew's yearly revenue for 2023 was $5.55B, representing an increase of 6.40% compared to 2022. The company's yearly revenue for 2022 was $5.22B, representing an increase of 0.06% compared to 2021. SNN's yearly revenue for 2021 was $5.21B, representing an increase of 14.30% compared to 2020.

What is Smith & Nephew’s quarterly revenue?

Smith & Nephew's quarterly revenue for Q4 2023 was $2.79B, a 2.14% increase from the previous quarter (Q2 2023), and a 113.59% increase year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $2.73B, a 100.00% increase from the previous quarter (Q1 2023), and a 5.15% increase year-over-year (Q2 2022). SNN's quarterly revenue for Q1 2023 was $1.37B, a -50.16% decrease from the previous quarter (Q4 2022), and a 5.15% increase year-over-year (Q1 2022).

What is Smith & Nephew’s revenue growth rate?

Smith & Nephew's revenue growth rate for the last 3 years (2021-2023) was 6.47%, and for the last 5 years (2019-2023) was 8.00%.

What are Smith & Nephew’s revenue streams?

Smith & Nephew's revenue streams in c 23 are Advanced Wound Management, Orthopaedics, Sports Medicine and Ear Nose and Throat, and Orthopaedics, Sports Medicine and ENT and Advanced Wound Management. Advanced Wound Management generated $1.61B in revenue, accounting 14.47% of the company's total revenue, up 6.22% year-over-year. Orthopaedics, Sports Medicine and Ear Nose and Throat generated $3.94B in revenue, accounting 35.53% of the company's total revenue, up 6.48% year-over-year. Orthopaedics, Sports Medicine and ENT and Advanced Wound Management generated $5.55B in revenue, accounting 50.00% of the company's total revenue, up 6.40% year-over-year.

What is Smith & Nephew’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Smith & Nephew was Orthopaedics, Sports Medicine and ENT and Advanced Wound Management. This segment made a revenue of $5.55B, representing 50.00% of the company's total revenue.